The San Diego-based medical device company received a U.S. Justice Dept. subpoena in April 2011, seeking information related to its relationships with healthcare professionals. Two more subpoenas connected to the case were issued, in Sepember 2011 and August 2012.
CareFusion and the Justice Dept. initially agreed to the settlement in April 2013. CareFusion completed its last payment at the beginning of this month, according to a regulatory filing.
“We are pleased to resolve this matter and are confident we have strong practices, processes and controls in place. We have made significant investments during the past several years to improve our quality and compliance systems, including our sales and marketing practices, and will continue to do so as part of our commitment to adhering to the highest standards and aligning with best global practices,” chairman & CEO Kieran T. Gallahue said in prepared remarks.
Earlier this month CareFusion closed its purchase of Totowa, N.J.-based Vital Signs from GE Healthcare (NYSE:GE) for $500 million.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.